Exclusive

Publication

Byline

Orion and Shilpa Medicare expand partnership to develop Nivolumab Biosimilar for Europe

Singapore, July 7 -- Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals has entered into a co-development and supply agreement with Orion Corporation, a globally operat... Read More


Korea's Neurophet to supply neurodegenerative brain imaging analysis software to Raffles Medical in Singapore

Singapore, July 7 -- South Korea-based Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has signed a supply agreement with Raffles Medical for i... Read More


Sanyou Bio and Baiyunshan Xihe join forces to advance innovative radiopharma and radiodiagnostics

Singapore, July 6 -- China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the official signing of a strategic cooperation agreement. This par... Read More


UCL and Eisai renew partnership to accelerate treatments for neurodegenerative diseases

Singapore, July 6 -- University College London (UCL) and Japanese pharma firm Eisai have signed a new agreement to extend their long-standing collaboration in drug discovery and development for five m... Read More


Matica Bio, VaxDome partner on antigen-agnostic antiviral-vaccine hybrids

Singapore, July 6 -- Matica Biotechnology has entered a partnership with VaxDome to support development of antigen-agnostic antiviral-vaccine hybrid candidates. Under the agreement, Matica Bio will p... Read More


Ascletis submits US IND applications for once-monthly obesity candidates

Singapore, July 6 -- Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates ASC36 and ASC36_35 FDC. ASC36 is a next-generation peptid... Read More


Insilico Medicine inks deal worth $600 M with Takeda to advance strategic AI drug discovery

Singapore, July 3 -- Hong Kong-based Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, has announced a strategic collaboration agreement with Japanese pharma firm Takeda ... Read More


Agilent launches AI-driven analysis module for Agilent xCELLigence RTCA eSight

Singapore, July 3 -- Agilent Technologies Inc. has announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing ... Read More


MIT- Koch Institute to advance AI-driven cancer research in Abu Dhabi

Singapore, July 3 -- The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and US-based MIT - Koch Institute for Integrative Cancer Research have announced... Read More


South Korea's STARMED secures US FDA clearance for thyroid nodule ablation

Singapore, July 3 -- STARMED, a South Korea-based medical device company specialising in minimally invasive treatment technologies, has announced that it has obtained 510(k) clearance from the US Food... Read More